REGENTIS BIOMATERIALS LTD. RGNT
NYSE American · XASE · stock
REGENTIS BIOMATERIALS LTD. statistics & valuation
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 |
|---|---|---|
| Return on assets | -179.2% | 996.1% |
| Return on equity | -287.7% | -11.7% |
Source: SEC EDGAR filings · CIK 0001912966 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.